Portfolio Lab

Elanco Animal Health Inc

  • Stock
  • Ticker ELAN
  • ISIN US28414H1032
  • NYSE

Health care · Pharmaceuticals · USA

$25.74 −2.09%
Close of 20 Nov 2026
Open in backtest

Performance, volatility and drawdowns of Elanco Animal Health Inc since 09/2018, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.

Performance

ELANGlobal equities (VT)

$10,000 grew to $7,828. Global equities (VT): $14,653.

Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.

Declines from the peak

Lowest point −78.0% in 05/2023, measured from the peak in 08/2021. The old peak has not been reached again yet.

1-year return
+21.2%
5-year return p.a.
−4.3%
Return p.a. since 09/2018
−4.0%
Volatility p.a.
44.4%
Largest decline
−78.0%

Financial statements

Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures

Quarter end12/202403/202506/202509/202512/202503/202606/202609/2026
Income statement
Revenue1,0201,1931,2411,1371,1441,3711,3681,265
Gross profit519684713607589785798720
Net income-8.06711-34-276575418
Earnings per share-0.020.130.02-0.07-0.560.110.110.04
Balance sheet
Total assets12,61412,94113,74213,55113,35813,22213,56113,340
Liabilities6,5186,5886,9676,8026,8116,7226,9736,712
Equity6,0966,3536,7756,7496,5476,5006,5886,628
Cash468487539505545428530465
Long-term debt4,2774,3513,9543,7693,7623,7363,6633,449
Cash flow
Operating cash flow177-4.023721910813277216
Capital expenditure-47-65-57-92-62-51-33-60
Free cash flow130-6918012746-38244156

Value it:DCF calculatorMultiples calculator

Annual returns

Best year 2025 at +86.9%, weakest 2022 at −56.9%. 3 of 7 full years were positive. * partial year.

Quarterly reports

Filing date with the SEC and earnings per share of the quarter

DayEarnings per share
6 Nov 2026$0.04
5 Aug 2026$0.11
6 May 2026$0.11
24 Feb 2026−$0.56
5 Nov 2025−$0.07
7 Aug 2025$0.02
7 May 2025$0.13
25 Feb 2025−$0.02
7 Nov 2024$0.73
8 Aug 2024−$0.10
8 May 2024$0.06
26 Feb 2024−$0.29

Key metrics

Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.

Valuation

Market cap
€12bn
Market cap in trading currency
$12.9bn
Enterprise value
$15.8bn
P/E
–
P/S
2.50
P/B
1.94
EV/Sales
3.08
EV/EBITDA
51.6
Earnings yield
–
FCF yield
3.2%

Results (last four quarters)

Revenue
$5.15bn
Gross profit
$2.89bn
EBITDA
$307m
Net income
−$147m
Earnings per share
−$0.30
Revenue per share
$10.30
Revenue growth
+11.3%
Earnings growth
–

Profitability

Gross margin
56.2%
Operating margin
-1.8%
Net margin
-2.9%
Return on equity
-2.2%
Return on assets
-1.1%

Balance sheet and cash flow

Cash
$465m
Cash per share
$0.93
Financial debt
$3.45bn
Debt/equity %
52
Current ratio
2.09
Book value per share
$13.26
Operating cash flow
$614m
Free cash flow
$408m

Dividend

Dividend yield
0.00%
Dividend (12 months)
$0.00
Yield (12 months)
0.00%
Payout ratio
–
Ex-dividend date
–

Shares and trading

Shares outstanding
500m
Volume
5.76m
Avg. volume 3 months
5.28m
Relative volume
1.1

Price and technicals

Price
$25.74
1 day
−2.1%
52-week high
$26.84
52-week low
$19.80
Distance to 52-week high
−4.1%
Distance to 52-week low
+30.0%
Distance to 50-day line
+8.9%
Distance to 200-day line
+7.7%
RSI (14)
56
Volatility 1M
49.6%

Performance

1 week
−3.9%
1 month
+13.4%
3 months
+5.4%
6 months
+18.5%
YTD
+13.7%
1 year
+19.9%

Dates

Fiscal year end
31 Dec 2025
Most recent quarter
30 Sep 2026

Frequently asked questions

How has ELAN performed since 09/2018?

$10,000 grew to $7,150 by 20 Nov 2026, which is −4.0% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.

How volatile is ELAN?

Volatility was 44.4% per year, measured on monthly returns. The largest decline from a peak was −78.0%, with the low in 05/2023.

How does ELAN compare with a broad equity ETF?

Over the same period Global equities (VT) returned +10.1% per year at 16.5% volatility, ELAN returned −4.0% at 44.4%. The correlation of monthly returns was 0.49; 1 would mean they moved in lockstep.

Which currency are the figures in?

In US dollars, the currency of the US listing.

Not investment advice. Metrics and financial statements calculated from the company's mandatory filings with the SEC, without guarantee; amounts in US dollars.

Reference data of securities: source ESMA (FIRDS reference data) and SEC (EDGAR).

Not investment advice: results in Portfolio Lab are model calculations based on historical data and your inputs. Past performance is not a reliable indicator of future results.

Elanco Animal Health Inc (ELAN): Return and risk